Everything below concerns anti-doping. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2025-10-19. Numbers and descriptions here follow the published literature rather than marketing material.
SR9009 is a synthetic small molecule studied as an agonist of REV-ERB nuclear receptors. REV-ERB alpha and REV-ERB beta help regulate circadian rhythms and metabolic gene expression. In laboratory research, SR9009 has been used to probe how these receptors affect skeletal muscle, liver, and adipose tissue. The compound was identified in academic drug-discovery work and is often described in scientific literature by its chemical name and research code. It is not an approved medicine, and human clinical data remain limited or absent.
SR9009 binds REV-ERB receptors and alters their repressive activity on target genes. This action can change transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. In rodent studies, treated animals have shown changes in muscle oxidative capacity and exercise performance, though effects vary by dose, duration, and model. The precise molecular steps connecting receptor binding to whole-body outcomes are still an active area of investigation. Findings in animals do not automatically translate to humans.
At the molecular level, SR9009 binds the ligand-binding domain of REV-ERB and strengthens recruitment of corepressor proteins such as NCoR and HDAC3. This increases repression of target genes, including Bmal1 and other clock-controlled and metabolic genes. In rodent studies, such changes have been linked to altered lipid handling, glucose metabolism, and energy expenditure. The precise chain of events between receptor binding and whole-body effects remains an active area of research. Findings in animals do not automatically translate to humans.
Laboratory studies often administer SR9009 by injection because oral absorption appears poor in rodents. Reported pharmacokinetic properties include rapid metabolism and low systemic exposure after oral dosing. Human pharmacokinetic data are sparse, so absorption, distribution, metabolism, and excretion in people are not well defined. Some research explores related REV-ERB compounds with improved drug-like properties. Regulatory approval for any REV-ERB agonist as a human medicine has not been granted to date.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic REV-ERB agonist | Small-molecule nuclear receptor ligand |
| Appearance | Off-white to pale yellow solid | Typical for research-grade powder |
| Solubility class | Soluble in DMSO; low water solubility | Common stock solutions use organic solvent |
| Typical stock solvent | Dimethyl sulfoxide | Used for laboratory assays |
| Common analytical method | HPLC with UV or mass detection | Used for identity and purity checks |
SR9009 is supplied as a solid research chemical, often in milligram quantities. Laboratories typically weigh it in a controlled environment because fine powders can disperse. Stock solutions are commonly prepared in dimethyl sulfoxide and stored in small aliquots to reduce freeze-thaw cycles. Personal protective equipment and chemical fume hoods are standard when handling unknown or potent compounds. These practices address laboratory safety rather than human use.
Identity and purity of SR9009 samples are usually checked with chromatographic and spectrometric methods. High-performance liquid chromatography can separate the compound from related impurities, while mass spectrometry provides molecular mass confirmation. Nuclear magnetic resonance spectroscopy may be used for structural verification in research settings. No single method proves biological activity, and certificates of analysis should be reviewed alongside raw data. Independent testing is often needed because online products vary widely.
SR9009 stability depends on temperature, moisture, light, and solvent. Solid material is generally kept cool and dry, while solutions may require protection from repeated warming and cooling. Degradation can appear as color changes, precipitate, or new chromatographic peaks. Researchers should follow supplier instructions and their own stability data. Long-term storage conditions for human use have not been established because the compound lacks approved clinical formulation.
Regulatory agencies have not approved SR9009 for human therapeutic use. It is typically sold as a research chemical with labels stating that it is not for human consumption. The World Anti-Doping Agency prohibits the substance in sport, generally under the category of non-approved substances. Customs and national laws may restrict importation, sale, or possession. Product quality and legal status can vary by country and vendor, and therapeutic claims are not permitted in regulated advertising because the compound lacks approval.
Several misconceptions surround SR9009. It is often described as a SARM, a steroid, or an exercise pill, but its known target is the REV-ERB receptor family. Rodent studies have examined exercise capacity and metabolic markers, yet human outcomes remain unproven. Oral bioavailability appears low in animals, and human pharmacokinetics are not well characterized. Online products may contain impurities or different compounds, so identity and purity testing are important for research use.
Analytical chemists detect SR9009 with liquid chromatography-tandem mass spectrometry, commonly abbreviated LC-MS/MS. Sample preparation may involve protein precipitation, liquid-liquid extraction, or solid-phase extraction before analysis. Laboratories can target the parent compound or its metabolites, depending on the matrix and the purpose of testing. Anti-doping methods require sensitive and specific assays because concentrations in biological samples can be low. Reference standards and validated methods are essential for reliable identification and quantification.
== External links == The Scar Free Foundation website The Scar Free Foundation 2022 Impact Report Centre for Appearance Research, UWE The Scar Free Foundation and Health and Care Research Wales Programme of Regenerative Medicine
=== Multilayer approaches === In the case of Multi-layer flat textiles where one or more layer(s) remains sturdy an overlay fabric can be used to secure the damaged layer(s) to an undamaged layer when the weakened layer(s) are separated from the sturdy layer(s), a full backing sewn or adhesive should be used to reattach it. Disassembly is avoided as it requires the removal of original stitching.
Neanderthals, nonetheless, were frequently victims of animal attacks. There are multiple instances of Neanderthals practicing cannibalism, though it may have only been done in times of extreme food shortages, as in some cases in recorded human history.
=== Reproduction === Ginkgo biloba is dioecious, with separate sexes, some trees being female and others being male. Male plants produce small pollen cones with sporophylls, each bearing two microsporangia spirally arranged around a central axis. Sex conversion, wherein certain branches of a tree change sexes, has been observed. This phenomenon is difficult to research because of its rarity, as well as the practice of grafting female branches onto otherwise male trees that was common in 19th century Europe. Female plants do not produce cones. Two ovules are formed at the end of a stalk.
Sources: en.wikipedia.org
=== Withdrawals === 1 January 2009 – The U.S.–Iraq Status of Forces Agreement went into effect, and gave the Government of Iraq de jure responsibility of maintaining and providing security for all of its people. Approximately 150,000 foreign troops in Iraq. 28 June 2009 – Foreign forces were no longer stationed within any of Iraq's major cities. Proclaimed as a national holiday by Iraqi Prime Minister Nouri al-Maliki. 31 July 2009 – The last large groups of non-U.S. foreign forces completed their withdrawal from Iraq. 1 January 2010 – The major commands Multi-National Force – Iraq, Multi-National Corps – Iraq and Multi-National Security Transition Command – Iraq merged into the unified command United States Forces – Iraq, reducing the total number of staff positions by 41%. Approximately 112,000 U.S. troops in Iraq. 7 March 2010 – Iraq held parliamentary elections, its second under its democratic constitution, and is seen as an important milestone for the young Iraqi political system; this leaves approximately 96,000 U.S. troops in Iraq. 1 September 2010 – American forces ceased all combat operations, i.e. patrolling, serving arrest warrants, route clearance, etc., and transitioned to a pure advise, train and assist role. Operation Iraqi Freedom is officially concluded, and the advise and assist mission continues under Operation New Dawn. 49,700 U.S. troops in Iraq. 31 December 2011 – U.S. Army and U.S. Marine Corps units and formations complete their withdrawal from Iraq.
== Properties == The fungus Aspergillus fumigatus is capable of incorporating tellurocysteine (and telluromethionine) into proteins when grown in appropriate media. When incorporated into glutathione transferase, tellurocysteine efficiently inhibits aminoacylation and increases the efficiency of glutathione peroxidase.
=== Human rights === The drug conventions have been criticized for contributing to violations of the human rights principles enshrined in the Universal Declaration of Human Rights. Some scholars have also pointed at a violations of a number of international human right provisions contained in instruments such as the International Covenant on Civil and Political Rights, International Covenant on Economic, Social and Cultural Rights, International Convention on the Elimination of All Forms of Racial Discrimination, among others.
Sources: en.wikipedia.org
In the last 50 years, fashion in India has changed a great deal. In urban northern India, the sari is increasingly no longer everyday wear, though it remains popular on formal occasions. Younger urban women rarely wear the traditional shalwar kameez, favouring churidars or jeans. In office settings, ubiquitous air conditioning allows men to wear sports jackets year-round. For weddings and formal occasions, men in the middle and upper classes often wear bandhgala, or short Nehru jackets, with pants, with the groom and his groomsmen sporting sherwanis and churidars.
Agaricales (including now-obsolete orders Lycoperdales, Tulostomatales, and Nidulariales) Basidiomycetes: Agaricales: Lycoperdaceae: Calvatia Calvatia booniana Calvatia bovista (Handkea utriformis) Calvatia craniiformis Calvatia cyathiformis Calvatia fumosa (Handkea fumosa) Calvatia gigantea Calvatia lepidophora Calvatia rubroflava Calvatia sculpta Calvatia subcretacea (Handkea subcretacea) Basidiomycetes: Agaricales: Lycoperdaceae: Lycoperdon Lycoperdon foetidum (Lycoperdon nigrescens) Lycoperdon perlatum Lycoperdon pulcherrimum Lycoperdon pusillum Lycoperdon pyriforme Basidiomycetes: Agaricales: Lycoperdaceae: Vascellum Vascellum curtisii Vascellum pratense – edible when interior is white Geastrales and Phallales (related to Cantharellales), Basidiomycetes: Phallales: Geastraceae: Geastrum Geastrum coronatum Geastrum fornicatum Geastrum saccatum Sclerodermatales (related to Boletales) Basidiomycetes: Boletales: Sclerodermataceae: Scleroderma Scleroderma areolatum Scleroderma bovista Scleroderma cepa Scleroderma citrinum Scleroderma meridionale Scleroderma michiganense Scleroderma polyrhizum Scleroderma septentrionale Various false-truffles (hypogaeic gasteromycetes) related to different hymenomycete orders Similarly, the true truffles (Tuberales) are gasteroid Ascomycota. Their ascocarps are called tuberothecia.
== Preparations == Prescription products can be immediate release (Niacor, 500 mg tablets) or extended release (Niaspan, 500 and 1000 mg tablets). Niaspan has a film coating that delays release of the nicotinic acid, resulting in an absorption over a period of 8–12 hours. This reduces vasodilation and flushing side effects, but increases the risk of hepatotoxicity compared to the immediate release drug. Prescription nicotinic acid preparations in combination with statin drugs (discontinued) are described above. A combination of niacin and laropiprant had been approved for use in Europe and marketed as Tredaptive. Laropiprant is a prostaglandin D2 binding drug shown to reduce niacin-induced vasodilation and flushing side effects. A clinical trial showed no additional efficacy of Tredaptive in lowering cholesterol when used together with other statin drugs, but did show an increase in other side effects. The study resulted in the withdrawal of Tredaptive from the international market.
== Folding of macromolecules == In the case of protein folding, the hydrophobic effect is important to understanding the structure of proteins that have hydrophobic amino acids (such as valine, leucine, isoleucine, phenylalanine, tryptophan and methionine) clustered together within the protein. Structures of globular proteins have a hydrophobic core in which hydrophobic side chains are buried from water, which stabilizes the folded state. Charged and polar side chains are situated on the solvent-exposed surface where they interact with surrounding water molecules. Minimizing the number of hydrophobic side chains exposed to water is the principal driving force behind the folding process, although formation of hydrogen bonds within the protein also stabilizes protein structure. The energetics of DNA tertiary-structure assembly were determined to be driven by the hydrophobic effect, in addition to Watson–Crick base pairing, which is responsible for sequence selectivity, and stacking interactions between the aromatic bases.
Sources: en.wikipedia.org
SR9009 is a synthetic research compound that acts on REV-ERB nuclear receptors. It is not approved for human use and is sold only as a research chemical. Its effects have been studied mainly in cells and rodents.
It binds REV-ERB alpha and REV-ERB beta and changes the expression of genes tied to metabolism and circadian rhythm. These changes can affect mitochondria and energy use in animal models. The exact chain from receptor binding to physiological outcome is still being mapped.
No reliable human trials show that SR9009 improves athletic performance. Some rodent studies report endurance changes, but these results are not proof of human benefit. Its use in sport is prohibited, and quality and safety data are lacking.
SR9009 is a synthetic research compound that activates the REV-ERBα and REV-ERBβ nuclear receptors. It is not an approved drug and has no established human therapeutic use. Most published biological data come from cell and rodent studies.